Inclusion body myositis and associated diseases: an argument for shared immune pathologies.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
03 06 2022
Historique:
received: 24 05 2022
accepted: 25 05 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 9 6 2022
Statut: epublish

Résumé

Inclusion body myositis (IBM) is the most prevalent idiopathic inflammatory myopathy (IIM) affecting older adults. The pathogenic hallmark of IBM is chronic inflammation of skeletal muscle. At present, we do not classify IBM into different sub-entities, with the exception perhaps being the presence or absence of the anti-cN-1A-antibody. In contrast to other IIM, IBM is characterized by a chronic and progressive disease course. Here, we discuss the pathophysiological framework of IBM and highlight the seemingly prototypical situations where IBM occurs in the context of other diseases. In this context, understanding common immune pathways might provide insight into the pathogenesis of IBM. Indeed, IBM is associated with a distinct set of conditions, such as human immunodeficiency virus (HIV) or hepatitis C-two conditions associated with premature immune cell exhaustion. Further, the pathomorphology of IBM is reminiscent of other muscle diseases, notably HIV-associated myositis or granulomatous myositis. Distinct immune pathways are likely to drive these commonalities and senescence of the CD8

Identifiants

pubmed: 35659120
doi: 10.1186/s40478-022-01389-6
pii: 10.1186/s40478-022-01389-6
pmc: PMC9164382
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

84

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Ann Neurol. 2017 Feb;81(2):227-239
pubmed: 28009083
Nature. 2021 Jun;594(7861):100-105
pubmed: 33981041
Clin Neurol Neurosurg. 2011 Sep;113(7):559-63
pubmed: 21507567
Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):
pubmed: 33811141
Front Immunol. 2018 Jun 05;9:1200
pubmed: 29922285
Toxicol Pathol. 2014 Jul;42(5):811-22
pubmed: 24067671
Nat Rev Dis Primers. 2016 Jul 07;2:16047
pubmed: 27383445
Front Immunol. 2019 May 09;10:1040
pubmed: 31143183
Radiol Case Rep. 2020 Dec 17;16(3):433-437
pubmed: 33363677
J Neuropathol Exp Neurol. 2008 Jan;67(1):41-9
pubmed: 18091562
Curr Drug Targets. 2017;18(7):844-850
pubmed: 26844564
J Neurovirol. 2018 Oct;24(5):557-569
pubmed: 29785584
Ann Rheum Dis. 2016 Apr;75(4):696-701
pubmed: 25714931
Curr Opin Rheumatol. 2021 Nov 1;33(6):537-543
pubmed: 34494607
Immunology. 2011 Sep;134(1):17-32
pubmed: 21711350
Neuropathol Appl Neurobiol. 1993 Oct;19(5):406-13
pubmed: 8278024
Autophagy. 2007 Jul-Aug;3(4):384-6
pubmed: 17438365
Neurology. 2022 Mar 29;98(13):e1374-e1383
pubmed: 35131904
Brain. 2016 May;139(Pt 5):1348-60
pubmed: 26920676
Aging Cell. 2018 Apr;17(2):
pubmed: 29517845
Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452
pubmed: 29845092
J Immunol. 2005 May 15;174(10):6088-94
pubmed: 15879103
EBioMedicine. 2019 Nov;49:381-388
pubmed: 31662290
Rheumatology (Oxford). 2021 Jul 1;60(7):3398-3403
pubmed: 33367878
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):457-64
pubmed: 26088683
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1296-1298
pubmed: 30975823
Ann Neurol. 2007 May;61(5):466-75
pubmed: 17366634
Neurology. 2017 Apr 11;88(15):1454-1460
pubmed: 28283597
Acta Neuropathol. 2015 May;129(5):611-24
pubmed: 25579751
J Immunol. 2014 Mar 1;192(5):2143-55
pubmed: 24501199
Nat Rev Rheumatol. 2019 May;15(5):257-272
pubmed: 30837708
Nat Rev Rheumatol. 2018 May;14(5):269-278
pubmed: 29651121
Brain. 2019 Sep 1;142(9):2590-2604
pubmed: 31326977
Neurology. 2022 Mar 29;98(13):521-522
pubmed: 35131907
Neuromuscul Disord. 2015 Apr;25(4):281-8
pubmed: 25638290
Ann Rheum Dis. 2017 Dec;76(12):1955-1964
pubmed: 29079590
Immun Ageing. 2008 Jul 25;5:6
pubmed: 18657274
Curr Opin Neurol. 2016 Oct;29(5):662-73
pubmed: 27538058
Front Neurol. 2019 Jun 04;10:554
pubmed: 31214105
J Neurol Sci. 2009 Mar 15;278(1-2):25-9
pubmed: 19101700
N Engl J Med. 1990 Apr 19;322(16):1098-105
pubmed: 2320079
J Neuropathol Exp Neurol. 2016 Mar;75(3):239-45
pubmed: 26843609
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 10;6(3):e558
pubmed: 31044146
Immunity. 2007 Oct;27(4):670-84
pubmed: 17950003
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1056-60
pubmed: 18258695
Rheumatology (Oxford). 2008 Sep;47(9):1433-5
pubmed: 18611922
Acta Haematol. 2010;124(1):5-8
pubmed: 20501987
J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):674-7
pubmed: 20562458
JCI Insight. 2016 Jun 2;1(8):
pubmed: 27358913
Neuromuscul Disord. 2019 Jan;29(1):39-47
pubmed: 30578101
Int J Lab Hematol. 2022 Feb;44(1):27-28
pubmed: 34562064
Ann Neurol. 1988 Feb;23(2):168-73
pubmed: 3288082
Neurology. 1978 Jan;28(1):8-17
pubmed: 201886
Top Antivir Med. 2017 Feb/Mar;25(1):3-6
pubmed: 28402927
Front Cell Dev Biol. 2020 Mar 26;8:200
pubmed: 32274386
Brain Pathol. 2021 May;31(3):e12931
pubmed: 33354847
Rheumatology (Oxford). 2002 Apr;41(4):440-4
pubmed: 11961175
Can J Neurol Sci. 1986 Nov;13(4):334-6
pubmed: 3779534
Rheumatology (Oxford). 2022 May 5;61(5):2016-2024
pubmed: 34534271
Chembiochem. 2013 Mar 18;14(5):607-16
pubmed: 23450708
Sci Transl Med. 2022 Jan 19;14(628):eabi9196
pubmed: 35044790
Autoimmun Rev. 2014 Apr-May;13(4-5):372-4
pubmed: 24424169
Eur J Neurol. 2015 Apr;22(4):672-e41
pubmed: 25530508
Rheumatology (Oxford). 2020 Oct 1;59(10):3003-3013
pubmed: 32159757
J Neuropathol Exp Neurol. 2021 Oct 13;80(11):1060–1067
pubmed: 34643702
Fukuoka Igaku Zasshi. 2001 Nov;92(11):370-6
pubmed: 11774706
Neuromuscul Disord. 2015 Sep;25(9):706-12
pubmed: 26143153
Clin Immunol. 2008 Mar;126(3):235-42
pubmed: 17916442
Rheumatol Int. 2019 Aug;39(8):1459-1466
pubmed: 31055642
Neurology. 2020 Mar 3;94(9):e910-e920
pubmed: 31882529
Neurology. 2016 Jan 19;86(3):211-7
pubmed: 26683644
Immun Ageing. 2016 Mar 31;13:10
pubmed: 27034702
Ann Neurol. 2017 Apr;81(4):512-525
pubmed: 28318044
Front Immunol. 2021 Feb 02;11:594658
pubmed: 33603736
Semin Arthritis Rheum. 2006 Apr;35(5):306-11
pubmed: 16616153
BMJ Open. 2014 Apr 28;4(4):e004552
pubmed: 24776709

Auteurs

Christopher Nelke (C)

Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225, Düsseldorf, Germany.

Felix Kleefeld (F)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Corinna Preusse (C)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Neurology With Institute for Translational Neurology, University Hospital Münster, 48149, Münster, Germany.

Tobias Ruck (T)

Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225, Düsseldorf, Germany.

Werner Stenzel (W)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. werner.stenzel@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH